Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases

Fibrosing ILDs can develop a progressive phenotype and are described under the terminology PF-ILDs. Due to commonalities with IPF, the potential efficacy and tolerability of antifibrotic drugs pirfenidone and nintedanib are currently evaluated in PF-ILDs. http://bit.ly/2koL0A4

Detalles Bibliográficos
Autor principal: Cottin, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2019
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488849/
https://www.ncbi.nlm.nih.gov/pubmed/31578213
http://dx.doi.org/10.1183/16000617.0109-2019
_version_ 1784792752110698496
author Cottin, Vincent
author_facet Cottin, Vincent
author_sort Cottin, Vincent
collection PubMed
description Fibrosing ILDs can develop a progressive phenotype and are described under the terminology PF-ILDs. Due to commonalities with IPF, the potential efficacy and tolerability of antifibrotic drugs pirfenidone and nintedanib are currently evaluated in PF-ILDs. http://bit.ly/2koL0A4
format Online
Article
Text
id pubmed-9488849
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-94888492022-11-14 Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases Cottin, Vincent Eur Respir Rev Editorial Fibrosing ILDs can develop a progressive phenotype and are described under the terminology PF-ILDs. Due to commonalities with IPF, the potential efficacy and tolerability of antifibrotic drugs pirfenidone and nintedanib are currently evaluated in PF-ILDs. http://bit.ly/2koL0A4 European Respiratory Society 2019-10-02 /pmc/articles/PMC9488849/ /pubmed/31578213 http://dx.doi.org/10.1183/16000617.0109-2019 Text en Copyright ©ERS 2019. https://creativecommons.org/licenses/by-nc/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Editorial
Cottin, Vincent
Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases
title Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases
title_full Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases
title_fullStr Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases
title_full_unstemmed Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases
title_short Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases
title_sort treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488849/
https://www.ncbi.nlm.nih.gov/pubmed/31578213
http://dx.doi.org/10.1183/16000617.0109-2019
work_keys_str_mv AT cottinvincent treatmentofprogressivefibrosinginterstitiallungdiseasesamilestoneinthemanagementofinterstitiallungdiseases

Ejemplares similares